Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...

The FDA's breakthrough therapy designation facilitates accelerated development and regulatory review for therapies showing ...

The cell and gene therapy sector has never lacked attention, but all too often, the narrative swings from one extreme to ...

We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...

According to Mayo Clinic, stem cells are a special type of cell that have two important properties that make more cells like themselves.

The immune system is made up of different types of cells, which have different roles in protecting the body from infection. One type of immune cell called a B cell creates antibodies that attack ...

"Regulatory flexibility must be tailored for cell and gene therapies," commented FDA Commissioner Marty Makary. "These are common-sense reforms that will address the unique characteristics of cell and ...

Lumacyte CEO on how real-time insight is driving down manufacturing failures and opening doors for more patients.

A new cancer therapy wakes up immune cells inside tumors and turns them against cancer.

During a live event, Omid Hamid, MD, discussed the logistics and multidisciplinary process of using tumor-infiltrating ...